Resectable Cholangiocarcinoma
1 clinical trials · Condition
◉ Watch Resectable Cholangiocarcinoma
| Record | Firm | Date |
|---|---|---|
| Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer (NCT03579771) | Emory University | 2018-09-26 |
Track Resectable Cholangiocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.